₹ 340000
10% OFF for Senior Citizens | USE CODE SS10 *
|
|
Oncotype Dx Breast Cancer (ML) Test |
|
|
NA |
|
|
|
|
₹ 340000 |
@3x.png)
Description
The Oncotype Dx test is a tumour profiling diagnostic tool designed to assess the potential benefits of including chemotherapy alongside hormone therapy in the treatment plan for certain cases of early-stage breast cancer. This Oncotype Dx test is made for breast cancer cases that are estrogen receptor-positive and HER2-negative.
Oncotype Dx is currently the only tumour profiling test incorporated into breast cancer staging. It is used for tumors that are ER-positive, HER2-negative and have not spread to the lymph nodes. The Oncotype Dx test results, combined with other diagnostic data, assist in determining the stage of breast cancer.
Furthermore, it provides valuable insight into: -
Understanding what the Oncotype Dx test is all about can help patients feel more empowered during treatment planning. For women diagnosed with breast cancer, the Oncotype DX test has proven advantageous.
....Read More
Recommended Tests
FAQs
Description
The Oncotype Dx test is a tumour profiling diagnostic tool designed to assess the potential benefits of including chemotherapy alongside hormone therapy in the treatment plan for certain cases of early-stage breast cancer. This Oncotype Dx test is made for breast cancer cases that are estrogen receptor-positive and HER2-negative.
Oncotype Dx is currently the only tumour profiling test incorporated into breast cancer staging. It is used for tumors that are ER-positive, HER2-negative and have not spread to the lymph nodes. The Oncotype Dx test results, combined with other diagnostic data, assist in determining the stage of breast cancer.
Furthermore, it provides valuable insight into: -
Understanding what the Oncotype Dx test is all about can help patients feel more empowered during treatment planning. For women diagnosed with breast cancer, the Oncotype DX test has proven advantageous.
....Read MoreThe Oncotype Dx test is a tumour profiling diagnostic tool designed to assess the potential benefits of including chemotherapy alongside hormone therapy in the treatment plan for certain cases of early-stage breast cancer.
The Oncotype Dx breast cancer test is administered after the initial breast cancer surgery and is only available through prescription by a qualified healthcare professional, such as a surgical oncologist or medical oncologist. It is recommended for individuals who meet certain criteria, including: -
This Oncotype Dx test plays a significant role in helping oncologists decide whether chemotherapy is necessary in addition to hormone therapy. At Max Lab, the Oncotype Dx test cost is affordable across our wide network of diagnostic labs.
Max Lab provides reliable services for such diagnostic testing, ensuring that experienced professionals handle sample collection and processing. Patients can choose to view their results digitally or retrieve them in person, depending on their preference. Once the Oncotype DX test sample has been obtained, the report is generally ready in three weeks.
Once the Oncotype Dx test report is ready, the findings must be reviewed by a medical expert who can interpret the score and guide further treatment. Depending on the results, the physician may confirm the suitability of hormone therapy alone or recommend the inclusion of chemotherapy. This tailored approach supports better patient outcomes by avoiding unnecessary treatments and focusing on what is most beneficial based on the tumour’s biological profile.
.png)
7982100200
Test Name 
Sample Type 
Gender 
Age group 
This Test Includes 
Price
To reach our help desk call 9213188888